Grant name: NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
Funding organization: National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)
Total funding amount: Up to $450,000 in direct costs over a three-year period
Primary objective: To support studies that inform the planning of Phase II-IV clinical trials for heart, lung, blood, or sleep disorders
Funding source: Federal government
Funding type: Grant
Grant frequency: Recurring
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits Other Than Institutions of Higher Education
For-Profit Organizations
Small Businesses
Local Governments
State Governments
County Governments
City or Township Governments
Indian/Native American Tribal Governments (Federally Recognized)
Indian/Native American Tribal Governments (Other than Federally Recognized)
Federal Governments
U.S. Territory or Possession
Other: Independent School Districts, Public Housing Authorities, Faith-based Organizations, Regional Organizations
Foreign Organizations (non-domestic entities) are not eligible to apply.
Research must address heart, lung, blood, or sleep disorders.
Studies should fill critical information gaps necessary for clinical trial planning.
Investigators must have the skills, knowledge, and resources necessary to carry out the proposed research.
Maximum budget: $450,000 over three years.
Maximum direct costs in any single year: $225,000.
Open Date: January 16, 2025
Application Due Dates: Various dates from February 16, 2025, to October 16, 2026.
Expiration Date: January 08, 2027
Applications must comply with NIH Grants Policy Statement and other federal regulations.
Future Clinical Trial Description (required)
FDA Approval documentation (if applicable)